Helicobacter pylori (HP) is a bacterial agent associated with peptic ulcer disease and cancers of the human gastrointestinal tract. HP infections are highly prevalent throughout the world. The infection is treatable with antibiotics; however untreated HP infections can lead to stomach cancer thus enhancing the need for, and the benefit of, testing for HP infection. Current diagnostic methods require sophisticated laboratory equipment and take several days to complete.
MedMira’s rapid HP test can deliver highly accurate results to patients and their healthcare providers within minutes, enabling the right treatment to begin immediately. Reveal HP Rapid Test (Reveal HP) detects HP antibodies in serum, plasma or whole blood produced in response to HP infection. The presence of HP antibodies is indicative of exposure to the agent, and assists in the confirmation of HP infection with additional tests.
MedMira's rapid H.Pylori test is FDA approved in the United States.
